Format

Send to

Choose Destination
Clin Chim Acta. 2006 Oct;372(1-2):206-9. Epub 2006 May 15.

The effect of aspirin and vitamins C and E on HbA1c assays.

Author information

1
Clinical Pathology Department, Hospital de ClĂ­nicas de Porto Alegre, Porto Alegre, RS, Brazil. jcamargo@hcpa.ufrgs.br

Abstract

BACKGROUND:

Aspirin (ASA) and vitamins C and E may inhibit non-enzymatic glycation in vivo and may also interfere with HbA(1c) assays, masking true results. We investigated the effect of usual doses of ASA, vitamin C and E on HbA1c levels in a group of non-diabetic volunteers.

METHODS:

A randomized clinical trial was performed with 28 healthy non-diabetic individuals. Subjects were allocated to take ASA 200 mg/day, vitamin C 1 g/day, vitamin E 400 mg/day, or to a control group, for a period of 4 months. Blood samples were collected at baseline and at monthly intervals for HbA1c analysis by HPLC Variant II (BioRad), HPLC L-9100 (Merck - Hitachi) and Tina Quant HbA(1c) II immunoassay (Roche).

RESULTS:

HbA(1c) levels of the control, vitamin C and E groups did not change throughout the study, independently of the method used. HbA(1c) measured by Hitachi L-9100 HPLC increased significantly (P=0.033) at 4 months after ASA intake, although this increase was of only 0.17%.

CONCLUSIONS:

Treatment with vitamins C and E in pharmacological doses does not have any impact on HbA1c measurements in non-diabetic patients with the three methods employed. ASA induces a modest, not clinically relevant, increase in HbA1c levels with one of the methods.

PMID:
16698007
DOI:
10.1016/j.cca.2006.03.031
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center